MHR
ABBV icon

Matthew Hamilton Rosenberg’s AbbVie ABBV Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.08M Hold
4,135
– – 0.19% 61
2026
Q2 		$1.04M Buy
4,135
+141
+4% +$30.3K 0.19% 57
2026
Q1 		$869K Buy
3,994
+116
+3% +$25.7K 0.18% 60
2025
Q4 		$886K Sell
3,878
-11
-0.3% -$2.51K 0.18% 56
2025
Q3 		$901K Hold
3,889
– – 0.19% 55
2025
Q2 		$722K Buy
3,889
+450
+13% +$83.6K 0.17% 58
2025
Q1 		$721K Buy
3,439
+278
+9% +$54K 0.18% 55
2024
Q4 		$562K Buy
3,161
+174
+6% +$32K 0.15% 67
2024
Q3 		$590K Buy
2,987
+37
+1% +$6.91K 0.15% 69
2024
Q2 		$503K Sell
2,950
-455
-13% -$75.4K 0.15% 71
2024
Q1 		$615K Buy
3,405
+30
+0.9% +$5.17K 0.18% 61
2023
Q4 		$523K Buy
3,375
+81
+2% +$11.8K 0.16% 66
2023
Q3 		$491K Sell
3,294
-88
-3% -$12.9K 0.16% 63
2023
Q2 		$456K Sell
3,382
-749
-18% -$110K 0.15% 69
2023
Q1 		$658K Sell
4,131
-92
-2% -$14.1K 0.21% 56
2022
Q4 		$683K Buy
4,223
+100
+2% +$15.3K 0.23% 55
2022
Q3 		$553K Buy
4,123
+240
+6% +$34.4K 0.21% 58
2022
Q2 		$597K Buy
3,883
+301
+8% +$46K 0.23% 61
2022
Q1 		$581K Buy
3,582
+261
+8% +$37.9K 0.2% 63
2021
Q4 		$450K Buy
3,321
+250
+8% +$29.5K 0.16% 73
2021
Q3 		$331K Buy
3,071
+787
+34% +$89.9K 0.13% 99
2021
Q2 		$257K Hold
2,284
– – 0.13% 99
2021
Q1 		$247K Hold
2,284
– – 0.14% 94
2020
Q4 		$245K Sell
2,284
-93
-4% -$8.94K 0.15% 82
2020
Q3 		$208K Hold
2,377
– – 0.15% 86
2020
Q2 		$233K Buy
2,377
+547
+30% +$48.2K 0.19% 70
2020
Q1 		$140K Buy
+1,830
New +$156K 0.14% 86

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Matthew Hamilton Rosenberg's ABBV Position: Q3 2026 in Review

Matthew Hamilton Rosenberg held its AbbVie (ABBV) position steady in Q3 2026 at 4,135 shares worth $1.08M. The position accounts for 0.19% of the portfolio, ranked #61.

Matthew Hamilton Rosenberg first reported a position in ABBV in Q1 2020 and has held it in 27 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Matthew Hamilton Rosenberg held 4,135 shares of AbbVie worth $1.08M as of Q3 2026.
  • Matthew Hamilton Rosenberg left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.19% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #61 holding.
  • Matthew Hamilton Rosenberg first reported a position in AbbVie in Q1 2020 and has held it in 27 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.